Thymol

Thymol

SCHEMBL429155

COC.Cc1ccc(C(C)C)c(O)c1.Cc1ccc(C(C)C)c(O)c1

nearest known ligand 0.88

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.88
TRPA1 O75762 2/20 0.88
CHRM1 P11229 1/20 0.88
SLC6A2 P23975 1/20 0.88
ADRA1A P35348 1/20 0.88
HTR2B P41595 1/20 0.88
SRC P12931 1/20 0.47
IDO1 P14902 1/20 0.45
TDO2 P48775 1/20 0.45
GABRA1 P14867 1/20 0.45
GABRB2 P47870 1/20 0.45
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thymol SCHEMBL357328 1.00 LMNA (0.88) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL29579824 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL30332213 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL1867982 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL22165 0.94 LMNA (1.00) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL23932298 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL8506977 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL4729745 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL7074408 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A
Thymol SCHEMBL1668335 0.91 LMNA (0.95) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595642-A2 COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS The Procter and Gamble Company (US) 2013-05-29 EP disclosed
WO-2012012385-A2 COMPOSITIONS COMPRISING DERIVATIVES OF ESSENTIAL OIL COMPOUNDS AND USE IN PERSONAL CARE PRODUCTS THE PROCTER & GAMBLE COMPANY (US) 2012-01-26 WO disclosed